Aldehídos

3-(4-Bromophenyl)-1H-pyrazole-4-carbaldehyde (BPYCA) is a potent anticancer agent that targets cancer cells. It inhibits the growth and spread of cancer cells by inducing apoptosis. BPYCA also protects against DNA damage caused by formylation, which leads to cell death. BPYCA has been shown to be effective against breast cancer (MCF-7) and colon cancer (HCT116). BPYCA has been found to reduce the viability of MCF-7 cells, while HCT116 cells show increased sensitivity to this drug. The anti-cancer effects of BPYCA are potent and selective for cancerous cells, as it does not affect normal cells such as erythrocytes or platelets.

Please enquire for more information about 2,3-Dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-n-Propylbenzaldehyde is a chemical compound that belongs to the group of aromatic aldehydes. It is used in the production of other chemicals, such as pharmaceuticals and fragrances. 4-n-Propylbenzaldehyde has been shown to be genotoxic, causing DNA damage and mutating genes. This chemical also has an inhibitory effect on cancer cells, which may be due to its ability to interfere with histone deacetylase activity. The genotoxic potential of this substance is considered low based on its lack of genotoxicity in vitro and in vivo. This compound does not have any structural formula for the corresponding metal complex.